Han B, Liu J, Wu L, Zhao Y, et al. Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study. J Thorac Oncol 2025 Feb 8:S1556-0864(25)00062.
PMID: 39929334